Updated Jul 16, 2026
Lang James Paul has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
James Paul Lang is listed as a director of BioVie Inc. (BIVI) in the company’s SEC filing dated January 9, 2026 (CIK 0001703090). The filing notes no stock purchases or sales by him at that time, indicating a governance role rather than active trading activity in that period.
| Role | Director |
|---|---|
| Notability | 35/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-10 | OPRX | OptimizeRx Corp | A — Grant or award | 34.5K | $0.00 | |
| 2026-05-07 | HALO | HALOZYME THERAPEUTICS, INC. | A — Grant or award | 3.8K | $0.00 |
James Paul Lang is listed as a director of BioVie Inc. (BIVI) in the company’s SEC filing dated January 9, 2026 (CIK 0001703090). The filing notes no stock purchases or sales by him at that time, indicating a governance role rather than active trading activity in that period.…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Lang James Paul profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.